Clinical Trials Browser

Terminated × NIH × Nasopharyngeal Neoplasms × Clear all

NCT00393224 2020-06-04

Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Neoplasms, Virus Diseases

NCT01257100 2020-06-04

Environmental and Genetic Determinants of NPC

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Epstein-Barr Virus Infections